In this interactive, CME-certified Webcast, experts review the latest updates in CAR-T cell therapy and offer their insights on current best practices for patients with hematologic cancers.
Review my approach to CAR T-cell therapy—including considerations for patient candidacy and managing toxicities—illustrated with a patient case from my practice.
In this commentary, Matthew J. Frigault, MD, highlights key studies of CAR T-cell therapy that will be presented at the upcoming 2019 ASH annual meeting in Orlando.
Read expert answers to audience questions from a recent symposium on current best practices and emerging directions in CAR T-cell therapy.
Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with ALL.
Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with lymphomas.
Download this slideset for expert perspectives on emerging strategies in the use of CAR T-cell therapy for patients with multiple myeloma.
Download this slideset for expert perspectives on managing toxicities associated with CAR T-cell therapy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.